Picodya to play key role in Israel’s war on coronavirus
Picodya Technologies Ltd. receives approval for a third program from the Israeli Innovation Authority, including a substantial grant offered as part of a large-scale initiative to promote the development of breakthrough technologies that will help to combat the current coronavirus pandemic and advance public health in Israel. Picodya will adapt its innovative B-Matrix™ platform to conduct point-of-care serological testing for a panel of respiratory diseases, including COVID-19.
If you’re interested in Picodya and learning more about our game-changing B-Matrix™ technology, simply enter your details below. We’ll be happy to share further details and discuss our vision for better, cheaper, more accessible diagnostics worldwide.